Patents by Inventor Andrew-Elliot Greene

Andrew-Elliot Greene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030013889
    Abstract: Taxane derivatives and a method of preparing taxane derivatives of formula (I): 1
    Type: Application
    Filed: June 26, 2002
    Publication date: January 16, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Jean-Noel Denis, Andrew-Elliot Greene, Alice Kanazawa
  • Patent number: 6500953
    Abstract: The invention concerns the preparation of nothapodytine or camptothecin derivatives which consists in causing 4-ethyl 2methyl hepta-2,4-dienoic acid act on a 3-aminomethyl 2-bromo quinoline derivative (III) wherein R1 and R2 are H or R1 is a halogen atom or alkyl, R2 is a O—CO—X radical as defined for the camptothecin derivatives; or R1 and R2 are defined for the known camptothecin derivatives or represent protected radicals or radicals easily convertible into the radicals R1 and R2, to obtain the quinoline derivative (IV); adding to the resulting quinoline derivative (2-methoxy carbonyl vinyl) tributyltin in the presence of a complex of palladium and triphenylarsin to obtain the quinoline derivative (V); cyclizing the resulting quinoline derivative to obtain the tetracyclic derivative (VI); then in subjecting said derivative to an ozonolysis followed by treatment with dimethyl sulphide to obtain the tetracyclic derivative (VII); saponification followed by decarboxylation in oxidising conditions o
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: December 31, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Khalid Mekouar, Yves Genisson, Stefanie Leue, Andrew-Elliot Greene
  • Patent number: 6486320
    Abstract: The present invention relates to a novel process for preparation of camptothecin and of its derivatives by convergent synthesis starting from a 3-(aminomethyl)quinoline derivative and 5-hydroxy-5-ethyl-6-oxo-5,6-dihydropyrancarboxylic acid and to the intermediates obtained.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: November 26, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Stefanie Leue, Stéphanie Garçon, Andrew-Elliot Greene, Yves Génisson, Patrick Léon
  • Patent number: 6433180
    Abstract: Novel carboxylic acids of formula (VI), useful for preparing taxane derivatives of general formula (I) by esterifying protected baccatine (III) or protected diacetyl baccatin (III) with an acid of general formula (II). The products of general formula (I) are particularly useful for preparing taxol, Taxotere and analogs thereof having anti-tumor properties.
    Type: Grant
    Filed: August 8, 1997
    Date of Patent: August 13, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Noel Denis, Andrew-Elliot Greene, Alice Kanazawa
  • Publication number: 20020045756
    Abstract: The present invention relates to a novel process for preparation of camptothecin and of its derivatives by convergent synthesis starting from a 3-(aminomethyl)quinoline derivative and 5-hydroxy-5-ethyl-6-oxo-5,6-dihydropyrancarboxylic acid and to the intermediates obtained.
    Type: Application
    Filed: September 14, 2001
    Publication date: April 18, 2002
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Stefanie Leue, Stephanie Garcon, Andrew-Elliot Greene, Yves Genisson, Patrick Leon
  • Patent number: 6114550
    Abstract: A .beta.-phenylisoserine derivative of general formula (I): ##STR1## in the form of a salt or an ester, in which Ar represent an aryl radical, R represents a phenyl or naphthyl or a O--R.sub.1 radical and G.sub.1 represents --CH.sub.2 --Ph radical; and a method of using the same for making taxane derivatives.
    Type: Grant
    Filed: November 10, 1997
    Date of Patent: September 5, 2000
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Noel Denis, Andrew-Elliot Greene, Alice Kanazawa
  • Patent number: 5977375
    Abstract: A compound of the formula I: ##STR1## wherein Ar represents an aryl radical;R.sub.1 represents a hydrogen atom, an aroyl radical, or a radical of the formula R.sub.4 --O--CO;R.sub.2 and R.sub.3 together form a 5- or 6-membered saturated heterocycle;G.sub.1 represents an acetyl radical or a protecting group of the hydroxyl functional group; andG.sub.2 represents a protecting group of the hydroxyl functional group.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: November 2, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Noel Denis, Andrew-Elliot Greene, Jean-Manuel Mas
  • Patent number: 5811550
    Abstract: Method for the preparation of 1,3-oxazolidin 5-carboxylic acid having the general formula (I) ##STR1## from a product having the general formula (II) ##STR2## In the general formulas (I) and (II), Ar is an aryl radical, R.sub.1 is a benzoyl radical or a radical R.sub.2 --O--CO-- wherein R.sub.2 is an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, phenyl or heterocyclyl radical, Ph is an optionally substituted phenyl radical, X is the residue of an optically active organic base or an alkoxy radical optionally substituted by a phenyl radical. The acids of formulas (I) and (II) are particularly useful in preparing taxol, Taxotere or analogs thereof which have remarkable antitumor and antileukemia properties.
    Type: Grant
    Filed: July 21, 1997
    Date of Patent: September 22, 1998
    Assignee: Rhone-Poulenc Rorer, S.A.
    Inventors: Jean-Noel Denis, Andrew-Elliot Greene, Alice Kanazawa
  • Patent number: 5726346
    Abstract: This invention relates to a method of stereoselective preparation of a derivative of .beta.-phenylisoserine of formula (I) by the action of an N-carbonyl-benzylimine of formula (II) on an optically active amide of a protected hydroxyacetic acid of formula (III), followed by hydrolysis of the product obtained. In formula (I), (II) or (III), R is an optionally substituted phenyl radical or R.sub.1 --O, Ar is an optionally substituted aryl radical and G.sub.1 is a hydroxy function protection grouping. The product of formula (I) is particularly useful in preparing taxol and Taxotere which have remarkable antitumor properties.
    Type: Grant
    Filed: April 5, 1995
    Date of Patent: March 10, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Noel Denis, Andrew-Elliot Greene, Alice Kanazawa
  • Patent number: 5717103
    Abstract: This invention relates to a method of preparing esters of baccatine III or 10-deacetylbaccatine III of formula (I) by esterification of protected baccatine III or 10-deacetylbaccatine III of formula (II) by means of an activated acid of formula (III). The esters of formula (I) can be used to prepare taxane derivatives having remarkable antileucemia and antitumor properties. In formulae (I), (II) and (III) Ar is an aryl radical, R.sub.1 is a hydrogen atom or an aryl radical or an R.sub.4 --O--CO-- radical (R.sub.4 =alkenyl, alkynyl, optionally substituted alkyl, cycloalkyl, cycloalkynyl, bicycloalkyl, phenyl, heterocyclyle) and R.sub.2 is a hydrogen atom, and R.sub.3 stands for a hydroxy function protection grouping, or R.sub.1 is defined as above and R.sub.2 and R.sub.3 together form a 5 or 6 membered, saturated heterocyclic ring, G.sub.1 is an acetyl radical or a hydroxy function protection grouping, G.sub.2 is a hydroxy function protection grouping, and X is an acyl radical, aryl, radical or halogen atom.
    Type: Grant
    Filed: April 5, 1995
    Date of Patent: February 10, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Noel Denis, Andrew-Elliot Greene, Jean-Manuel Mas
  • Patent number: 5686623
    Abstract: A method for preparing taxane derivatives of general formula (I) by esterifying protected baccatin III or protected 10-deacetyl baccatin III with an acid of general formula (II). In general formulae (I) and (II), Ar is an aryl radical; R.sub.1 and R.sub.2 which are the same or different, are a hydrogen atom, an alkyl, phenylalkyl, phenyl, alkoxyphenyl or dialkoxyphenyl radical, or R.sub.1 or R.sub.2, together with the carbon atom to which they are attached, form a 4-7 membered ring; R.sub.3 is an acetyl radical or a hydroxy function protective grouping, and R.sub.4 is a hydroxy function protective grouping; R is a phenyl radical or a radical of formula R.sub.5 --O-- wherein R.sub.5 -- is an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, phenyl or saturated or unsaturated nitrogenous heterocylcyl radical. The products of general formula (I) are particularly useful for preparing taxol, Taxotere and analogues thereof having remarkable antitumor properties.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: November 11, 1997
    Assignee: Rhone-Poulenc Rorer, S.A.
    Inventors: Jean-Noel Denis, Andrew-Elliot Greene, Alice Kanazawa
  • Patent number: 5292921
    Abstract: Process for the enantioselective preparation of phenylisoserine derivatives of general formula (I) ##STR1## from phenylglycine S(+) wherein R is a phenyl radical or a tert butoxy radical and R is an alcohol protective group.
    Type: Grant
    Filed: November 13, 1992
    Date of Patent: March 8, 1994
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Arlene Correa, Jean-Noel Denis, Andrew-Elliot Greene, David S. Grierson
  • Patent number: 5290957
    Abstract: A stereoselective process for preparing phenylisoserine derivatives is disclosed. Benzylamine is reacted with an agent for introducing a phenyl or a t-butoxycarbonyl group. The product undergoes double anionization and then is reacted with acrolein to provide a mixture of alcohol syn and anti diasteroisomers. The syn isomer is isolated by chromatography. Whereupon, the hydroxyl is protected and the product is oxidized to provide the phenylisoserine derivative.
    Type: Grant
    Filed: November 20, 1992
    Date of Patent: March 1, 1994
    Assignee: Rhone Poulenc Rorer S.A.
    Inventors: Arlene Correa, Jean-Noel Denis, Andrew-Elliot Greene